|
MTX3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.51190000028134E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.598540E-04 |
| Normal-vs-Stage2 |
2.476600E-01 |
| Normal-vs-Stage3 |
4.96059999743892E-08 |
| Normal-vs-Stage4 |
1.5446000034558E-09 |
| Stage1-vs-Stage2 |
4.191400E-01 |
| Stage1-vs-Stage3 |
1.599680E-02 |
| Stage1-vs-Stage4 |
9.768900E-04 |
| Stage2-vs-Stage3 |
4.895900E-02 |
| Stage2-vs-Stage4 |
1.820130E-02 |
| Stage3-vs-Stage4 |
4.760000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.59030000016436E-07 |
| Normal-vs-AfricanAmerican |
1.040910E-04 |
| Normal-vs-Asian |
4.145000E-01 |
| Caucasian-vs-AfricanAmerican |
6.716800E-01 |
| Caucasian-vs-Asian |
4.574600E-01 |
| AfricanAmerican-vs-Asian |
3.200000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.36569999997782E-06 |
| Normal-vs-Female |
4.41780000004499E-06 |
| Male-vs-Female |
9.487800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.8199000000082E-06 |
| Normal-vs-Age(41-60Yrs) |
2.36839999999683E-05 |
| Normal-vs-Age(61-80Yrs) |
1.50071999999168E-05 |
| Normal-vs-Age(81-100Yrs) |
6.641600E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.674100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.098500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.303800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.419600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.138400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.484000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.743000E-01 |
| Normal-vs-Grade 2 |
1.437670E-03 |
| Normal-vs-Grade 3 |
2.47040000012078E-07 |
| Normal-vs-Grade 4 |
3.26709992393148E-10 |
| Grade 1-vs-Grade 2 |
6.830800E-01 |
| Grade 1-vs-Grade 3 |
2.101200E-01 |
| Grade 1-vs-Grade 4 |
1.367910E-02 |
| Grade 2-vs-Grade 3 |
3.491800E-02 |
| Grade 2-vs-Grade 4 |
8.34620000000896E-05 |
| Grade 3-vs-Grade 4 |
2.355600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.824000E-03 |
| Normal-vs-ccB subtype |
1.05439999997792E-06 |
| ccA subtype-vs-ccB subtype |
2.097600E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.006640E-04 |
| Normal-vs-N1 |
6.2323999999947E-05 |
| N0-vs-N1 |
1.394570E-01 |
|
|
